Founded in 1950, the Injecta firm began production of these Injecta syringes at 600 per day as part of the German Democratic Republic's specialization program to increase public health care after the war and recovery years. The firm included the public consolidation of many pre-war factories that were left in barely functioning condition when the war ended.